PT1438336E - Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentos - Google Patents

Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentos

Info

Publication number
PT1438336E
PT1438336E PT02774712T PT02774712T PT1438336E PT 1438336 E PT1438336 E PT 1438336E PT 02774712 T PT02774712 T PT 02774712T PT 02774712 T PT02774712 T PT 02774712T PT 1438336 E PT1438336 E PT 1438336E
Authority
PT
Portugal
Prior art keywords
sialillacao
medicines
preparation
high level
fsh formulations
Prior art date
Application number
PT02774712T
Other languages
English (en)
Inventor
Loumaye Ernest
Giartosio Carlo Emanuele
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23323355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1438336(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of PT1438336E publication Critical patent/PT1438336E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
PT02774712T 2001-10-22 2002-10-15 Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentos PT1438336E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33808801P 2001-10-22 2001-10-22

Publications (1)

Publication Number Publication Date
PT1438336E true PT1438336E (pt) 2006-08-31

Family

ID=23323355

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02774712T PT1438336E (pt) 2001-10-22 2002-10-15 Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentos

Country Status (24)

Country Link
US (1) US20050085412A1 (pt)
EP (2) EP1438336B1 (pt)
JP (1) JP2005515974A (pt)
KR (1) KR100929971B1 (pt)
CN (1) CN1608078B (pt)
AR (1) AR036926A1 (pt)
AT (1) ATE329930T1 (pt)
AU (1) AU2002340562B2 (pt)
CA (1) CA2464368A1 (pt)
DE (1) DE60212425T2 (pt)
DK (1) DK1438336T3 (pt)
EA (1) EA007030B1 (pt)
ES (1) ES2261740T3 (pt)
HR (1) HRP20040278B1 (pt)
IL (2) IL161235A0 (pt)
ME (1) MEP38608A (pt)
MX (1) MXPA04003352A (pt)
NO (1) NO327966B1 (pt)
PL (1) PL369606A1 (pt)
PT (1) PT1438336E (pt)
RS (1) RS32804A (pt)
UA (1) UA87433C2 (pt)
WO (1) WO2003035686A2 (pt)
ZA (1) ZA200402279B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524782D0 (en) * 2005-12-05 2006-01-11 Chiron Srl Analysis of samples
ES2620261T3 (es) * 2006-09-10 2017-06-28 Glycotope Gmbh Uso de células humanas de origen leucémico mieloide para expresión de anticuerpos
CN101264096B (zh) * 2007-03-12 2011-11-09 中国医学科学院药物研究所 人参皂苷Rg1在制备生精产品中的应用
AU2008290217B2 (en) 2007-08-20 2013-09-05 Protalix Ltd. Saccharide-containing protein conjugates and uses thereof
TWI488640B (zh) * 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
EP2421434A4 (en) * 2009-04-22 2013-07-10 Univ California MAGNETIC RESONANCE SPECTROSCOPY 1H IN VIVO FOR THE DIAGNOSIS OF FUNCTION AND TESTICULAR DISEASES
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
CN102464713A (zh) * 2010-12-21 2012-05-23 上海丽珠制药有限公司 一种卵泡刺激素的制备方法
SI3272861T1 (sl) 2011-01-20 2020-06-30 Protalix Ltd. Alfa-galaktozidazni sestavki
CN103619358B (zh) 2011-03-31 2017-02-15 辉凌公司 药物制剂
AR090095A1 (es) * 2011-06-06 2014-10-22 Ferring Bv Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
BR112016023668A2 (pt) 2014-04-18 2017-10-17 Glycotope Gmbh hiperestimulação ovariana controlada com hormônio de estimulação de folículo humano recombinante aperfeiçoado
EP3794041B1 (en) 2018-05-18 2023-07-12 Glycotope GmbH Anti-muc1 antibody

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1057895B (it) * 1975-02-17 1982-03-30 Serono Lab Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US5338835A (en) * 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
US5541083A (en) * 1989-10-24 1996-07-30 The Regents Of The University Of California Method for producing secretable glycosyltransferases and other golgi processing enzymes
US5834251A (en) * 1994-12-30 1998-11-10 Alko Group Ltd. Methods of modifying carbohydrate moieties
WO1998031826A1 (en) * 1997-01-16 1998-07-23 Cytel Corporation Practical in vitro sialylation of recombinant glycoproteins
IL141063A (en) * 1998-08-07 2005-06-19 Applied Research Systems Derivatives of pyrrolidine-2-carboxylic acid and piperidine-2-carboxylic acids and pharmaceutical compositions comprising said derivatives for treating infertility
AU1326200A (en) * 1998-10-28 2000-05-15 Baylor College Of Medicine Ovary-specific genes and proteins
EP1171615B1 (en) * 1999-04-26 2006-12-13 Genentech, Inc. Cell culture process for glycoproteins
JP2001299362A (ja) * 1999-12-17 2001-10-30 Takeda Chem Ind Ltd 新規ポリペプチドおよびそのｄｎａ
AU2001231531A1 (en) * 2000-02-11 2001-08-20 Maxygen Aps Follicle stimulating hormones

Also Published As

Publication number Publication date
NO327966B1 (no) 2009-11-02
DE60212425D1 (de) 2006-07-27
DE60212425T2 (de) 2006-11-09
JP2005515974A (ja) 2005-06-02
HRP20040278A2 (en) 2005-04-30
CA2464368A1 (en) 2003-05-01
AU2002340562B2 (en) 2008-10-23
IL161235A0 (en) 2004-09-27
DK1438336T3 (da) 2006-10-02
NO20042061L (no) 2004-07-13
MEP38608A (en) 2011-02-10
EP1438336A2 (en) 2004-07-21
KR20040045885A (ko) 2004-06-02
WO2003035686A2 (en) 2003-05-01
ZA200402279B (en) 2005-10-26
EP1438336B1 (en) 2006-06-14
AR036926A1 (es) 2004-10-13
CN1608078A (zh) 2005-04-20
PL369606A1 (en) 2005-05-02
US20050085412A1 (en) 2005-04-21
EP1621549A2 (en) 2006-02-01
ATE329930T1 (de) 2006-07-15
EP1621549A3 (en) 2006-03-01
MXPA04003352A (es) 2004-07-08
KR100929971B1 (ko) 2009-12-04
IL161235A (en) 2009-07-20
ES2261740T3 (es) 2006-11-16
CN1608078B (zh) 2012-07-25
HRP20040278B1 (en) 2008-03-31
EA007030B1 (ru) 2006-06-30
UA87433C2 (ru) 2009-07-27
RS32804A (en) 2007-02-05
WO2003035686A3 (en) 2003-10-09
EA200400574A1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
PT1438336E (pt) Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentos
DE60107544D1 (de) Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
PT1270565E (pt) Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia
ATE355271T1 (de) Pharmazeutische zusammensetzung
NO20010013L (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
ITTO20010008A0 (it) Formulazione farmaceutica
ATE331529T1 (de) Antigen enthaltende pharmazeutische zusammensetzung
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
NO20032438D0 (no) Orto- og metasubstituerte bis-arylforbindelser, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
DE69525148T2 (de) Pharmazeutische formulierung
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
HK1115537A1 (en) A use of hydroalcoholic gel in the manufacture of medicine
EE200200484A (et) Väikeseannuseline entekaviiripreparaat ja selle kasutamine
DE60304993D1 (de) In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
NO20034159D0 (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
DE60211183D1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
DE59903028D1 (de) Levothyroxin natrium enthaltende pharmazeutische zubereitung
PT1187847E (pt) Derivados de estreptograminas sua preparacao e as composicoes que os contem
DE60129238D1 (de) Pharmazeutische zusammensetzung
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
IL159006A0 (en) Phenoxy-phenyl derivatives and pharmaceutical compositions containing the same